시장보고서

상품코드

1389606

세계 dPCR 및 qPCR 시장 규모 및 예측 - 지역별 점유율, 치료법, 제품, 용도, 최종 사용자별, 지역별 성장 기회 분석

dPCR and qPCR Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Product, Application, End User, and Geography

발행일: 2023년 11월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 159 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

dPCR과 qPCR 시장 규모는 2022년 89억 7,600만 달러에서 2030년에는 182억 3,000만 달러로 성장할 것으로 예측되며, 2022-2030년 CAGR은 9.3%로 추정됩니다.

dPCR과 qPCR 시장의 성장은 유전병과 감염의 발생률 증가, 유전자 합성에 대한 투자 및 자금 증가, PCR 기술의 기술적 진보로 인한 것입니다.

최근 PCR과 같은 분자 기법은 진단 기술로 발전해 왔습니다. 이 방법은 의료 전문가가 광범위한 감염을 정확하게 진단 할 수있게 해주며 필수적인 연구 및 진단 도구로 간주됩니다. PCR 방법은 1개의 DNA에서 수백만 사본의 DNA를 생성할 수 있습니다. 또한 질병의 조기 진단이 가능하기 때문에 질병의 통제에 필수적인 역할을 합니다. PCR은 다른 실험실간에 비교 가능한 재현성 있는 결과를 가져오므로 세계적으로 받아들여지고 있습니다. PCR 기술은 신흥국에서도 널리 받아들여지고 이용되고 있습니다. 세계보건기구(WHO)의 '개발도상국에서 PCR 검사시설 설립에 관한 보고서 2016'에 따르면 WHO는 WHO 동남아시아 국가의 총 11개 회원국에 PCR 검사시설을 설립하는데 필요한 기술지원을 실시하고 있습니다. 실험실은 고품질의 의료를 제공하는 데 도움이 될 것입니다. 이러한 PCR 실험실은 역전사효소 PCR(RT-PCR), 멀티플렉스 PCR, 실시간 PCR, In-situ PCR, 디지털 PCR(dPCR) 등, 필요에 따라 다양한 PCR 기술을 채용하고 있습니다. 쉽고, 신속하며, 특이성이 높은 질병의 스크리닝과 임상 미생물학, 바이러스학, 기생충학, 생명 공학 및 관련 분야에서의 응용이 증가함에 따라 신흥 국가의 dPCR 및 qPCR 시장은 예측 기간 동안 유리합니다. 기회를 경험할 것으로 예상됩니다.

액적 디지털 PCR(ddPCR)은 디지털 PCR을 수행하는 새로운 기술입니다. 물-오일 에멀젼 액적 기술을 이용합니다. 검사 샘플은 약 20,000개의 액적으로 분획되고, 각 액적에서 표적 DNA 사슬의 증폭이 수행됩니다. 그런 다음 ddPCR은 개별 액적에서 핵산 표적을 디지털 방식으로 측정합니다. 그러므로, 이 기술은 표적 DNA 분자의 정밀하고 절대적인 정량을 가능하게 하고 진단과 연구에 광범위하게 적용할 수 있습니다. qPCR에서 DNA 정량은 사이클 임계값(CT)에서 얻습니다. 외부 캘리브레이터가 필요하며 불완전한 증폭은 절대 정량에 영향을 미칩니다. 액적 디지털 PCR(ddPCR)은 검량선 없이 대상 DNA를 직접 계산합니다. 따라서 ddPCR의 출현으로 과학자들은 복잡한 유전적 경관을 탐색하고, 새로운 질병과의 연관성을 발견하고 검증하고, 분자진단의 새로운 시대를 정의할 수 있습니다. 따라서 ddPCR 시장 개발은 미래에 dPCR과 qPCR 시장의 큰 동향이 될 것으로 보입니다.

용도 기반 통찰

용도에 따라 dPCR과 qPCR 시장은 연구 용도, 임상 용도, 법의학 용도로 구분됩니다. 2022년에는 임상 응용 분야가 시장에서 가장 큰 점유율을 차지하고 2022-2030년 가장 높은 CAGR을 기록할 것으로 예상됩니다. 분자 생물학 기술은 질병 진단에 혁명을 일으키고 있으며, 이제 실험실 진단의 중요한 부분이되었습니다. dPCR과 qPCR 기술은 현재 당뇨병, 감염, 암 등을 비롯한 많은 질병의 진단에 사용되고 있습니다. 예를 들어, 소화기 감염, 병원 감염(HAI), 호흡기 감염, 성 감염 등의 진단을 위해 실시간 PCR 기술의 리다 제네 키트가 개발되었습니다. 이러한 분자적 접근법은 조기, 고감도, 특이적인 진단을 가능하게 하므로 임상 응용 분야는 예측 기간 동안 성장할 것으로 예상됩니다.

실시간 PCR 기술은 유전자의 돌연변이를 검출하는 데 사용되며 암 진단에 도움이 됩니다. dPCR은 또한 객담, 소변, 뇌척수액, 혈장과 같은 무세포 DNA(cfDNA) 샘플에서 종양 마커의 정확한 검출을 가능하게 합니다. 예를 들어, dPCR은 상피 성장 인자 수용체(EGFR), KRAS, ESR1의 돌연변이를 검출하는데 일반적으로 사용됩니다.

게다가 기술의 진보에 의해 암의 진단이나 치료를 위한 분자 마커가 제공되고 있습니다. 2023년 4월, Thermofisher Scientific은 QuantStudio Dx 시리즈용 CE-IVD 마크를 획득한 37가지 실시간 PCR 분석 키트를 발표하여 많은 감염을 감지할 수 있게 되었습니다.

최종 사용자 기반 통찰력

dPCR과 qPCR 시장은 최종 사용자를 기반으로 병원 및 진단센터, 제약 및 바이오테크놀러지 기업, 연구소 및 학술기관, 법의학연구소, 임상연구기관으로 구분됩니다. 2022년에는 병원과 진단센터 부문이 시장에서 가장 큰 점유율을 차지하고 2022-2030년에 가장 높은 CAGR을 기록할 것으로 예상됩니다.

dPCR과 qPCR 시장에서 병원과 진단센터는 큰 시장 점유율을 차지합니다. dPCR과 qPCR은 박테리아, 바이러스 및 곰팡이를 포함한 병원체의 조기 및 정확한 검출을 가능하게 하는 높은 감도와 특이성과 같은 이점을 제공합니다.

또한, 병원은 급성 및 만성 질환의 치료를 위해 환자에게 고급 진단 및 치료 옵션을 제공하며, 병원 및 진단센터는 의료 시설에 전문 과학 장비를 제공하기 때문에 PCR 기술 채용률은 크게 높아지고 있습니다. 또한 신흥국에서 의료 인프라의 지속적인 확대, 감염증 발생률 증가, 입원 환자 수 증가로 신속하고 민감한 진단 도구가 필요합니다. 또한 조기 및 효율적인 질병 진단 및 치료에 대한 수요 증가, 진단 용도의 dPCR 제품의 상시 수 증가, 질병 진단의 dPCR의 이점(다른 PCR 기술과 비교), 임상 진단 및 질병 진단 이러한 기술이 제공하는 이점에 대한 일반 시민의 의식 증가는 시장 성장을 뒷받침하고 있습니다.

게다가 진단 실험실에는 첨단기술이 충실하고, 검사하는 다양한 샘플의 워크플로우나 관리가 용이하게 되어 있습니다. 예를 들어, Thermo Fisher Scientific, Inc.는 QuantStudio 5, QuantStudio 6 Flex, QuantStudio 7, QuantStudio 12k, QuantStudio 3D, QuantStudio Absolute Q AutoRun dPCR Suite 등 여러 PCR 변형을 제공합니다. 마찬가지로 Bio-Rad Laboratories, Inc., Fluidigm Corporation, Eppendorf, Agilent Technologies, Inc.와 같은 여러 회사는 병원 및 진단센터의 능력과 요구에 따라 PCR 장비를 제공합니다.

미국 질병 예방관리센터(Centers for Disease Control and Prevention), 의학연구미래기금(Medical Research Future Fund), 세계보건기구(WHO) 등은 dPCR과 qPCR 시장보고 시에 참조한 1차 및 2차 조사 정보의 하나입니다.

시장 성장 촉진요인
- 유전병 및 감염증의 발생률 증가
- 유전자 합성에 대한 투자와 자금 증가
- PCR 기술의 기술적 진보
시장 성장 억제요인
- PCR 시스템의 고비용
- qPCR에 따른 기술적 한계
시장 기회
- 신흥국 PCR법 채용 확대
향후의 동향
- 액적 디지털 PCR의 발전
영향 분석

제6장 dPCR 및 qPCR 시장 - 세계 시장 분석

dPCR과 qPCR 시장의 수익(2022-2030년)

제7장 dPCR과 qPCR 세계 시장 - 치료별 수익과 예측(-2030년)

dPCR과 qPCR 시장의 수익 점유율, 치료별(2022년 및 2030년)
정량적 PCR
디지털 PCR

제8장 dPCR과 qPCR 세계 시장 - 제품별 수익과 예측(-2030년)

dPCR과 qPCR 시장의 수익 점유율, 제품별(2022년 및 2030년)
시약 및 소모품
장치
소프트웨어 및 서비스

제9장 dPCR과 qPCR 세계 시장 - 용도별 수익과 예측(-2030년)

dPCR과 qPCR 시장의 수익 점유율, 용도별(2022년 및 2030년)
조사 용도
임상용도
법의학 용도

제10장 dPCR 및 qPCR 세계 시장 - 최종 사용자별 수익과 예측

dPCR과 qPCR 시장의 수익 점유율, 최종 사용자별(2022년 및 2030년)
병원 및 진단센터
제약회사 및 바이오테크놀러지 기업
연구소 및 학술기관
법의학 연구소
임상연구기관

제11장 dPCR 및 qPCR 시장 분석 : 지역별

북미
- 멕시코
유럽
- 기타 유럽
아시아태평양
- 기타 아시아태평양
중동 및 아프리카
- 기타 중동 및 아프리카
중남미
- 기타 중남미

제12장 dPCR 및 qPCR 시장 - 업계 상황

dPCR과 qPCR 시장에서의 성장 전략
유기적 성장 전략
무기적 성장 전략

제13장 기업 프로파일

Abbott Laboratories
Thermo Fisher Scientific Inc
Takara Bio Inc
Qiagen NV
Standard BioTools Inc
Lepu Medical Technology Beijing Co Ltd
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories Inc
Agilent Technologies Inc
Genome Diagnostics Pvt Ltd

제14장 부록

JHS 23.12.15

The dPCR and qPCR market size is expected to grow from US$ 8.976 billion in 2022 to US$ 18.230 billion by 2030; it is estimated to record a CAGR of 9.3% during 2022-2030.

The dPCR and qPCR market growth is attributed to the increasing incidence of genetic and infectious diseases, rising investments and funds for gene synthesis, and technological advancements in PCR technologies.

In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. According to the World Health Organization Report on the Establishment of PCR Laboratory in Developing Countries 2016, WHO is providing necessary technical assistance to establish PCR laboratories in all 11 member states of the WHO South East Asia countries. The laboratories will help in providing high-quality medical care. These PCR laboratories have adopted different PCR technologies such as Reverse transcriptase PCR (RT-PCR), Multiplex PCR, Real-time PCR, In-situ PCR, Digital PCR (dPCR), and others depending on their need. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.

Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, the development of ddPCR would become a major trend in the dPCR and qPCR market in the future.

Application-Based Insights

Based on application, the dPCR and qPCR market is segmented into research application, clinical application, and forensic application. In 2022, the clinical application segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2030. Molecular biology techniques have revolutionized disease diagnosis and are now a crucial part of laboratory diagnostics. The dPCR and qPCR techniques are now being used in the diagnosis of many diseases, including diabetes, infectious diseases, cancer, and others. For instance, real-time PCR technology RIDA GENE kits are developed for the diagnosis of gastrointestinal infections, hospital-acquired infections (HAI), respiratory infections, sexually transmitted infections, and other parameters. As these molecular methods allow early, sensitive, and specific diagnosis, the clinical application segment is expected to witness growth over the forecast period.

Real-time PCR technologies have been used to detect mutation in genes, which helps in the diagnosis of cancer. dPCR also enables precise detection of tumor markers in cell-free DNA (cfDNA) samples like sputum, urine, cerebrospinal fluid, plasma, and others. dPCR is more effective in detecting single-nucleotide polymorphism among the wild-type sequences. For example, dPCR is commonly used to detect mutation in epidermal growth factor receptor (EGFR), KRAS, and ESR1.

Furthermore, technological advancements are offering molecular markers for diagnosing and treating cancer. In April 2023, Thermo Fisher Scientific introduced 37 CE-IVD-marked real-time PCR assay kits for its QuantStudio Dx series of instruments to detect numerous infectious diseases.

End User-Based Insights

Based on end user, the dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. In 2022, the hospitals and diagnostic centers segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2030.

Hospitals and diagnostic centers contribute a significant market share to the dPCR and qPCR market. Hospitals are the primary centers for a patient seeking highly advanced treatment under the guidance of much-trained personnel. dPCR and qPCR offer advantages such as high sensitivity and specificity, allowing early and accurate detection of pathogens, including bacteria, viruses, and fungi.

In addition, hospitals offer advanced diagnosis and treatment options for patients to treat acute and chronic conditions, and the adoption of PCR techniques is much higher in hospitals and diagnostic centers as they provide healthcare facilities with specialized scientific equipment. Moreover, the continued expansion of healthcare infrastructure across emerging countries, the high incidences of infectious diseases, and the growing number of hospital admissions has created a need for rapid and sensitive diagnostic tools. Additionally, growing demand for early and efficient disease diagnosis and treatment, the increasing number of dPCR product launches for diagnostic applications, the advantages offered by dPCR in disease diagnosis (as compared to other PCR technologies), and growing awareness among public associated with the benefits offered by both these technologies for clinical and disease diagnosis fuel the market growth.

Furthermore, diagnostic laboratories are well-equipped with hi-tech equipment that enables easy workflow and management of various samples to be tested. For instance, Thermo Fisher Scientific, Inc. offers multiple variants of its PCR, including QuantStudio 5, QuantStudio 6 Flex, QuantStudio 7, QuantStudio 12k, QuantStudio 3D, and QuantStudio Absolute Q AutoRun dPCR Suite. Similarly, several companies, such as Bio-Rad Laboratories, Inc., Fluidigm Corporation, Eppendorf, and Agilent Technologies, Inc., offer PCR devices to hospitals and diagnostic centers based on their capacity and requirements.

Centers for Disease Control and Prevention, Medical Research Future Fund, and the World Health Organization (WHO) are among the primary and secondary sources referred to while preparing the dPCR and qPCR market report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the dPCR and qPCR market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global dPCR and qPCR market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interests with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. dPCR and qPCR Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Global PEST Analysis

5. dPCR and qPCR Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Incidence of Genetic and Infectious Diseases
- 5.1.2 Rising Investments and Funds for Gene Synthesis
- 5.1.3 Technological Advancements in PCR Technologies
5.2 Market Restraints
- 5.2.1 High Costs of PCR Systems
- 5.2.2 Technical Limitations Associated with qPCR
5.3 Market Opportunities
- 5.3.1 Growing Adoption of PCR Methods in Emerging Countries
5.4 Future Trends
- 5.4.1 Development of Droplet Digital PCR
5.5 Impact Analysis:

6. dPCR and qPCR Market - Global Market Analysis

6.1 dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

7. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

7.1 Overview
7.2 dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Quantitative PCR
- 7.3.1 Overview
- 7.3.2 Quantitative PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Digital PCR
- 7.4.1 Overview
- 7.4.2 Digital PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

8.1 Overview
8.2 dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
8.3 Reagents & Consumables
- 8.3.1 Overview
- 8.3.2 Reagents & Consumables: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Instruments
- 8.4.1 Overview
- 8.4.2 Instruments: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Software & Services
- 8.5.1 Overview
- 8.5.2 Software & Services: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

9.1 Overview
9.2 dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Research Application
- 9.3.1 Overview
- 9.3.2 Research Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Clinical Application
- 9.4.1 Overview
- 9.4.2 Clinical Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.4.2.1 dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
9.5 Forensic Application
- 9.5.1 Overview
- 9.5.2 Forensic Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

10.1 Overview
10.2 dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
10.3 Hospitals and Diagnostic Centers
- 10.3.1 Overview
- 10.3.2 Hospitals and Diagnostic Centers: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical and Biotechnology Companies
- 10.4.1 Overview
- 10.4.2 Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research Laboratories and Academic Institutes
- 10.5.1 Overview
- 10.5.2 Research Laboratories and Academic Institutes: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Forensic Laboratories
- 10.6.1 Overview
- 10.6.2 Forensic Laboratories: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
10.7 Clinical Research Organizations
- 10.7.1 Overview
- 10.7.2 Clinical Research Organizations: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

11. dPCR and qPCR Market - Geographical Analysis

11.1 North America dPCR and qPCR Market, Revenue and Forecast To 2030
- 11.1.1 Overview
- 11.1.2 North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.3 North America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
- 11.1.4 North America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
- 11.1.5 North America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 11.1.5.1 North America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
- 11.1.6 North America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.1.6.1 North America dPCR and qPCR Market, by Country
  - 11.1.6.2 US
    - 11.1.6.2.1 US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.6.2.2 US: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.1.6.2.3 US: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.1.6.2.4 US: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.1.6.2.4.1 US: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.1.6.2.5 US: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.1.6.3 Canada
    - 11.1.6.3.1 Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.6.3.2 Canada: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.1.6.3.3 Canada: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.1.6.3.4 Canada: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.1.6.3.4.1 Canada: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.1.6.3.5 Canada: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.1.6.4 Mexico
    - 11.1.6.4.1 Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.6.4.2 Mexico: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.1.6.4.3 Mexico: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.1.6.4.4 Mexico: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.1.6.4.4.1 Mexico: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.1.6.4.5 Mexico: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.2 Europe dPCR and qPCR Market, Revenue and Forecast to 2030
- 11.2.1 Overview
- 11.2.2 Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.3 Europe: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
- 11.2.4 Europe: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
- 11.2.5 Europe: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 11.2.5.1 Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
- 11.2.6 Europe: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.2.6.1 Europe dPCR and qPCR Market, by Country
  - 11.2.6.2 UK
    - 11.2.6.2.1 UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.2.2 UK: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.2.6.2.3 UK: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.2.6.2.4 UK: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.2.6.2.4.1 UK: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.2.6.2.5 UK: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.2.6.3 Germany
    - 11.2.6.3.1 Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.3.2 Germany: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.2.6.3.3 Germany: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.2.6.3.4 Germany: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.2.6.3.4.1 Germany: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.2.6.3.5 Germany: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.2.6.4 France
    - 11.2.6.4.1 France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.4.2 France: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.2.6.4.3 France: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.2.6.4.4 France: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.2.6.4.4.1 France: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.2.6.4.5 France: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.2.6.5 Italy
    - 11.2.6.5.1 Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.5.2 Italy: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.2.6.5.3 Italy: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.2.6.5.4 Italy: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.2.6.5.4.1 Italy: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.2.6.5.5 Italy: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.2.6.6 Spain
    - 11.2.6.6.1 Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.6.2 Spain: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.2.6.6.3 Spain: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.2.6.6.4 Spain: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.2.6.6.4.1 Spain: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.2.6.6.5 Spain: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.2.6.7 Rest of Europe
    - 11.2.6.7.1 Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.7.2 Rest of Europe: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.2.6.7.3 Rest of Europe: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.2.6.7.4 Rest of Europe: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.2.6.7.4.1 Rest of Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.2.6.7.5 Rest of Europe: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.3 Asia Pacific dPCR and qPCR Market, Revenue and Forecast to 2030
- 11.3.1 Overview
- 11.3.2 Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.3 Asia Pacific: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
- 11.3.4 Asia Pacific: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
- 11.3.5 Asia Pacific: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 11.3.5.1 Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
- 11.3.6 Asia Pacific: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.3.6.1 Asia Pacific dPCR and qPCR Market, by Country
  - 11.3.6.2 China
    - 11.3.6.2.1 China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.2.2 China: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.3.6.2.3 China: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.3.6.2.4 China: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.3.6.2.4.1 China: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.3.6.2.5 China: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.3.6.3 Japan
    - 11.3.6.3.1 Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.3.2 Japan: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.3.6.3.3 Japan: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.3.6.3.4 Japan: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.3.6.3.4.1 Japan: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.3.6.3.5 Japan: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.3.6.4 India
    - 11.3.6.4.1 India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.4.2 India: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.3.6.4.3 India: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.3.6.4.4 India: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.3.6.4.4.1 India: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.3.6.4.5 India: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.3.6.5 Australia
    - 11.3.6.5.1 Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.5.2 Australia: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.3.6.5.3 Australia: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.3.6.5.4 Australia: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.3.6.5.4.1 Australia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.3.6.5.5 Australia: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.3.6.6 South Korea
    - 11.3.6.6.1 South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.6.2 South Korea: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.3.6.6.3 South Korea: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.3.6.6.4 South Korea: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.3.6.6.4.1 South Korea: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.3.6.6.5 South Korea: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.3.6.7 Rest of Asia Pacific
    - 11.3.6.7.1 Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.7.2 Rest of Asia Pacific: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.3.6.7.3 Rest of Asia Pacific: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.3.6.7.4 Rest of Asia Pacific: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.3.6.7.4.1 Rest of Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.3.6.7.5 Rest of Asia Pacific: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.4 Middle East & Africa dPCR and qPCR Market, Revenue and Forecast to 2030
- 11.4.1 Overview
- 11.4.2 Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.3 Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
- 11.4.4 Middle East & Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
- 11.4.5 Middle East & Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 11.4.5.1 Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
- 11.4.6 Middle East & Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.4.6.1 Middle East & Africa dPCR and qPCR Market, by Country
  - 11.4.6.2 Saudi Arabia
    - 11.4.6.2.1 Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.6.2.2 Saudi Arabia: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.4.6.2.3 Saudi Arabia: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.4.6.2.4 Saudi Arabia: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.4.6.2.4.1 Saudi Arabia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.4.6.2.5 Saudi Arabia: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.4.6.3 UAE
    - 11.4.6.3.1 UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.6.3.2 UAE: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.4.6.3.3 UAE: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.4.6.3.4 UAE: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.4.6.3.4.1 UAE: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.4.6.3.5 UAE: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.4.6.4 South Africa
    - 11.4.6.4.1 South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.6.4.2 South Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.4.6.4.3 South Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.4.6.4.4 South Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.4.6.4.4.1 South Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.4.6.4.5 South Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.4.6.5 Rest of Middle East & Africa
    - 11.4.6.5.1 Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.6.5.2 Rest of Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.4.6.5.3 Rest of Middle East & Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.4.6.5.4 Rest of Middle East & Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.4.6.5.4.1 Rest of Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.4.6.5.5 Rest of Middle East & Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.5 South & Central America dPCR and qPCR Market, Revenue and Forecast to 2030
- 11.5.1 Overview
- 11.5.2 South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.3 South & Central America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
- 11.5.4 South & Central America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
- 11.5.5 South & Central America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
  - 11.5.5.1 South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
- 11.5.6 South & Central America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.5.6.1 South & Central America dPCR and qPCR Market, by Country
  - 11.5.6.2 Brazil
    - 11.5.6.2.1 Brazil dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.6.2.2 Brazil: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.5.6.2.3 Brazil: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.5.6.2.4 Brazil: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.5.6.2.4.1 Brazil: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.5.6.2.5 Brazil: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.5.6.3 Argentina
    - 11.5.6.3.1 Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.6.3.2 Argentina: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.5.6.3.3 Argentina: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.5.6.3.4 Argentina: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.5.6.3.4.1 Argentina: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.5.6.3.5 Argentina: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  - 11.5.6.4 Rest of South & Central America
    - 11.5.6.4.1 Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.6.4.2 Rest of South & Central America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    - 11.5.6.4.3 Rest of South & Central America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    - 11.5.6.4.4 Rest of South & Central America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
    - 11.5.6.4.4.1 Rest of South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    - 11.5.6.4.5 Rest of South & Central America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

12. dPCR and qPCR Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in dPCR and qPCR Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Takara Bio Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Qiagen NV
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Standard BioTools Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Lepu Medical Technology Beijing Co Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 F. Hoffmann-La Roche Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Bio-Rad Laboratories Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Agilent Technologies Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Genome Diagnostics Pvt Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 SWOT Analysis
- 13.10.5 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms